abrdn UK Real Estate Share Fund

Select share classes
There is only one type of share class for this fund.

abrdn UK Real Estate Share Fund I Acc

Category Property - Indirect Other



This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

228.12p

arrow-down-2.14p (-0.93%)

Fund Code

ABPSA

B0XWNN6

GB00B0XWNN66

Prices updated as at 24 Apr 2024
|
Prices in GBX

Investment objective
To generate income and some growth over the long term (5 years or more) by investing in UK property-related equities (company shares) including listed closed ended real estate investment trusts (“REITs”). The fund invests in equities and equity-related securities of companies that derive a significant proportion of their revenues or profits from real estate operations or have a significant proportion of their assets in real estate. At least 80% of the fund must be invested in UK listed securities, while up to 20% may be invested overseas.

Fund statusOpen
Fund typeOpen Ended Investment Company
Fund managerRomney Fox
240.8
189.49
Fund comparative indexFTSE 350 Real Estate +3% TR GBP
Property Other
0.05
0.98
0.09
0.00
Property - Indirect Other
No
Fund providerabrdn Fund Managers Limited
Share class launch date01 Oct 2012
£211.32m
-
3.20
-
Semi-Annually
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.